Author:
Xia Hongping,Kong Shik Nie,Chen Jianxiang,Shi Ming,Sekar Karthik,Seshachalam Veerabrahma Pratap,Rajasekaran Muthukumar,Goh Brian Kim Poh,Ooi London Lucien,Hui Kam M.
Funder
SingHealth Foundation
National Medical Research Council of Singapore
Reference18 articles.
1. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma;Maluccio;CA Cancer J. Clin.,2012
2. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015
3. Facing the dawn of immunotherapy for hepatocellular carcinoma;Sprinzl;J. Hepatol.,2013
4. HCC therapies—lessons learned;Wörns;Nat. Rev. Gastroenterol. Hepatol.,2014
5. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial;Bruix;Lancet Oncol.,2015
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献